(MENAFNEditorial)
Fast Market Research announces the availability of Technavio's new report "Ablation Catheters Market in the US 2015-2019" on their comprehensive research portal.
Cardiac arrhythmia is one of the leading causes of premature death and is characterized by the abrupt loss of heart function. Cardiac dysfunction results in the inhibition of blood flow to the brain and other vital organs. Arrhythmia is a condition resulting in abnormal heartbeat which occurs due to changes in electrical impulses. The electrical impulses can either be too fast or too slow resulting in sudden cardiac arrest. According to a 2013 report by the AHA more than 450000 people die annually in the US because of sudden cardiac arrest.
Catheter ablation is an endovascular procedure that is helpful in the treatment of irregular heartbeat. Ablation catheters use an energy source such as radiofrequency which produces radio waves that generate heat. Ablation catheters reduce the risk of ventricular fibrillation and sudden cardiac arrest.
Technavio's analysts forecast the ablation catheters market in the US is expected to grow at a CAGR of 12.23% over the period 2014-2019.
Get More Details on this Report and a Full Table of Contents at
Commenting on the report an analyst from Technavio’s team said: “Vendors are focusing on developing innovative ablation catheter devices through application of advanced technology. They also aim to reduce the manufacturing costs to provide efficient and useful tools to deliver tailored treatments to patients. For instance St. Jude Medical received FDA approval for Flexibility Ablation Catheters an irrigated ablation catheter with a flexible tip in the US in January 2015.”
According to the report catheter ablation is a Minimally Invasive (MI) procedure that helps remove faulty electrical pathways in the heart. Atrial Fibrillation (AF) is one of the leading causes of stroke in the US and affects over 5 million people. About 240000 catheter ablation procedures were performed in the US in 2014. Therefore rise in incidence of AF has led to rise in demand for ablation catheter procedures.
Further the report states that shortage of skilled professionals is a major challenge restricting market growth.
The key players in the Ablation Catheters Market in the US are Biosense Webster (A J&J company) Boston Scientific Medtronic and St. Jude Medical while other prominent vendors include Advanced Cardiac Therapeutics Angiodynamics APT MEDICAL Atricure Biotronik CardioFocus Covidien DVx Edwards Lifesciences Estech Hansen Medical Imricor Medical Systems Japan Lifeline LEPU MEDICAL Melys AFSM MicroPort Osypka PLC Medical Systems Spectranetics and Stereotaxis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts we provide quick and easy access to the best competitive intelligence available. Our unbiased expert staff is always available to help you find the right research to fit your requirements and your budget.
For more information about these or related research reports please visit our website at or call us at 1.800.844.8156 (1.413.485.7001 Int'l)
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.